Biopharma, Payers Seek National Guidelines For Prescribing Potential COVID-19 Drugs
Executive Summary
Guidelines for US health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.